Practical AI in Healthcare

S1, E34 - Matt Truppo, PhD, Part 2: AI-Driven Drug Development at Sanofi: Clinical Trials, Regulatory, and Personal AI

56 min · 26. apr. 2026
episode S1, E34 - Matt Truppo, PhD, Part 2: AI-Driven Drug Development at Sanofi: Clinical Trials, Regulatory, and Personal AI cover

Description

In Part 2 of our conversation with Matt Truppo, Global Head of Research Platforms and Computational R&D at Sanofi, we move from discovery to development, where the real stakes begin. Matt unpacks the promise and limitations of “digital patient twins,” a concept often described as the holy grail of drug development. With nearly 90% of drugs failing in clinical trials, even modest gains in predicting efficacy or patient response could transform the industry. Through real-world examples, including Dupixent and rare disease therapies, Matt shows how quantitative systems pharmacology (QSP) and AI-driven simulations are already shortening timelines, reducing patient burden, and, in some cases, eliminating the need for entire trials. But the story doesn’t stop at modeling. We explore how AI is reshaping clinical operations, from Sanofi’s “clinical control tower” that integrates trial data across 4,000 users, to generative AI tools that are cutting regulatory document creation time by more than a third. Matt also shares a personal experiment, building a network of AI agents modeled on his own workflow, reclaiming 30% of his time and offering a glimpse into a more “agentic” future of work. The throughline is clear: AI is not replacing human expertise, but amplifying it, helping the industry finally bend the cost and time curve of drug development.

Comments

0

Be the first to comment

Sign up now and become a member of the Practical AI in Healthcare community!

Get Started

1 month for 9 kr.

Then 99 kr. / month · Cancel anytime.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

42 episodes

episode S1, E40 - Jeff Smith — AI Regulation, Transparency & Innovation from the Government Perspective artwork

S1, E40 - Jeff Smith — AI Regulation, Transparency & Innovation from the Government Perspective

What happens when the rules for getting AI into clinical care are written by someone who has spent his career inside both the advocacy world and the government? In this episode, we talk with Jeff Smith of ONC at HHS, the first government official on Practical AI in Healthcare. Smith walks us through ONC's proposed HTI-5 rule, including a striking move to treat AI agents as "users" with the same data-access rights as clinicians, and a new question about whether blocking data from being written back into the EHR is itself information blocking. We also dig into the limits of what a regulator can actually do, and why the real work is coordination across agencies rather than control from any one of them. https://practicalaiinhealthcare.com/ [https://practicalaiinhealthcare.com/] https://www.youtube.com/@PracticalAIinHealthcare [https://www.youtube.com/@PracticalAIinHealthcare]

7. juni 202643 min
episode S1, E39 - Sarah Rossetti, RN, PhD: Nursing Informatics & the CONCERN Early Warning System artwork

S1, E39 - Sarah Rossetti, RN, PhD: Nursing Informatics & the CONCERN Early Warning System

On National Nurses Day, Practical AI in Healthcare welcomes its first nurse: Sarah Rossetti, RN, PhD, of Columbia University. Her CONCERN early warning system takes an unusual approach to predicting patient deterioration. Instead of modeling a patient's vital signs and labs, it models the nurse's documentation behavior, since the frequency and timing of charting reflect clinical concern long before the numbers move. In a 74-unit randomized trial of more than 60,000 patients, published in Nature Medicine, CONCERN was associated with a 35.6% reduction in instantaneous mortality risk. Rossetti and the hosts unpack the method, the counterintuitive rise in ICU transfers, equity safeguards, and what ambient AI means for the signal. https://practicalaiinhealthcare.com/episodes/#S1E39 [https://practicalaiinhealthcare.com/episodes/#S1E39] More on Sarah Rossetti's work: https://www.dbmi.columbia.edu/profile/sarah-collins-rossetti/ [https://www.dbmi.columbia.edu/profile/sarah-collins-rossetti/]

31. maj 202653 min
episode S1, E38 - Reflections 5: How Specialized Does AI Have to Be to Actually Work? artwork

S1, E38 - Reflections 5: How Specialized Does AI Have to Be to Actually Work?

In their fifth Reflections episode, Steve and Leon look back across six conversations (Matt Truppo at Sanofi, Ted Shortliffe, Barry Chaiken, David Hidalgo-Gato, and Danny van Leeuwen) to ask a sharper question: how specialized does AI have to be to actually work? The throughline is depth. The LLM is a commodity, and so, increasingly, is the generalist agent. What stays scarce is specialization in a workflow, the revival of symbolic methods like knowledge graphs, the literacy that separates an AI's ~95% solo accuracy from the under-35% people get using it themselves, and leaders willing to use themselves as the test rig. After 37 episodes, the technology is no longer the question. The specificity of the work around it is.

24. maj 202634 min